Sort
82,697 grants matching “vaccine development”
Prime shock and kill for HIV erradication
$752,862Andrew D Badley · Mayo Clinic Rochester · R01 · FY2022 · AI
Prime shock and kill for HIV erradication
$752,862Andrew D Badley · Mayo Clinic Rochester · R01 · FY2019 · AI
Developing broad-spectrum therapeutics against C. difficile toxins
$752,846Rongsheng Jin · University Of California-Irvine · R01 · FY2024 · AI
Advanced Development and Clinical Evaluation of an Entamoeba histolytica Vaccine
$752,780Christopher Fox · Access To Advanced Health Institute · N01 · FY2019 · AI
Understanding the mechanisms of antibody-mediated transcytosis of ZIKV within the placenta
$752,750Mehul Shamal Suthar · Emory University · R01 · FY2024 · AI
Immunology/Influenza Virology Core
$752,713Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2018 · AI
HIV-1 membrane fusion and inhibition
$752,675Bing Chen · Boston Children'S Hospital · R01 · FY2025 · AI
STRUCTURAL STUDIES ON ROTAVIRUS
$752,646Bidadi V Venkataram Prasad · Baylor College Of Medicine · R01 · FY2025 · AI
Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem
$752,527Jessica Hartman · Cell Microsystems, Inc. · R44 · FY2024 · AI
Tfh dysfunction in HIV and Aging
$752,460Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2022 · AG
Factors Influencing Oral Transmission of SIV
$752,438Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2010 · DE
SpongeBot: genetically engineered cells to suppress SARS-CoV-2 and future viruses
$752,435Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2021 · EB
Mechanisms of repeated control of acute hepatitis C infection in humans
$752,418Andrea L Cox · Johns Hopkins University · U19 · FY2017 · AI
Immunity to Pneumonic Tularemia
$752,408Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Applying High-Performance Protein Engineering Tools to HIV Immunogen Design
$752,375Margaret E Ackerman · Dartmouth College · R01 · FY2014 · AI
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
$752,350Kathryn M Anastos · Albert Einstein College Of Medicine · U54 · FY2014 · CA
Partnership for Detection of Infection by Category B Pathogens
$752,345Frances S. Ligler · U.S. Naval Research Laboratory · U01 · FY2011 · AI
Optimization of novel phenotypic screening hits for treatment of Malaria
$752,336Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2021 · AI
Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
$752,296Peter G Szilagyi · University Of California Los Angeles · R01 · FY2021 · AI
Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists
$752,220David Joseph Diemert · George Washington University · U01 · FY2019 · AI
Western New England Maternal Pediatric Adolescent AIDS Clinical Trials Unit
$752,209Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · U01 · FY2011 · AI
Maternal Stress and the Gut-Brain Axis in African American Infants
$752,160Elizabeth J Corwin · Emory University · R01 · FY2016 · MD
The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV)
$752,119Nicholas T. Funderburg · Ohio State University · U01 · FY2024 · AI
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr
$752,108David Masopust · University Of Minnesota · R01 · FY2011 · AI
Membrane protein effectors of pathogen interactions with host
$752,107Francesca M Marassi · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2017 · GM